Neurochemical and/or pharmacological evidence suggests that the FSL rat exhibits changes consistent with the cholinergic, serotonergic, dopaminergic, NPY, and circadian rhythm models but not the noradrenergic, HPA axis or GABAergic models of depression.
These findings point to the potential of the NPY system for developing novel pharmacological treatments of stress-related disorders, including anxiety and depression.